Biotech

All Articles

Turnstone gives up 60%, shakes up C-suite to extend cash money

.Turnstone Biologics is actually reducing its headcount by 60% and shaking up its C-suite to maintai...

Gilead loses hope on $15M MASH wager after reviewing preclinical records

.In a year that has observed a permission and a range of readouts for metabolic dysfunction-associat...

Texas biotech centers cancer treaty, pins wishes on being overweight

.Alaunos Therapeutics is actually axing an arrangement along with Precigen, losing hope licensing le...

Capricor portions much more data for DMD treatment after launching BLA

.Capricor Therapies is taking a victory tour for their phase 2 Duchenne muscular dystrophy (DMD) tes...

FDA spots Kezar lupus trial in hold adhering to 4 person fatalities

.The FDA has actually placed Kezar Lifestyle Sciences' lupus trial on grip after the biotech warned ...

Phase 3 Intellectual Rock trial reaches SMA target, delivering stock up 200%

.A phase 3 test of Academic Stone's vertebral muscular degeneration (SMA) applicant has hit its key ...

CAMP 4 is actually latest to eye IPO, while Upstream point out $182M strategy

.RNA biotech CAMP4 Therapies has defined plans for a $67 million IPO, with inflammation-focused Upst...

Galecto purchases leukemia medicine, falls bone tissue cancer possession in pivot

.A year after the failing of an idiopathic lung fibrosis candidate sent out Galecto on a hunt for sa...

Judo throws down $100M to knock senseless kidney disease

.Taking the floor covering is actually Judo Biography, an up-and-coming biotech armed along with $on...

AstraZeneca spends CSPC $100M for preclinical cardiovascular disease drug

.AstraZeneca has actually paid off CSPC Drug Group $100 million for a preclinical cardiovascular dis...